Show simple item record

dc.contributor.advisorByrne, Mark
dc.contributor.authorWhite, Charles, Jr.
dc.date.accessioned2011-04-26T19:50:23Z
dc.date.available2011-04-26T19:50:23Z
dc.date.issued2011-04-26
dc.identifier.urihttp://hdl.handle.net/10415/2551
dc.description.abstractContact lens induced dry eye (CLIDE) affects approximately 80% of contact lens wearers. Extrapolating to the world wide population of 300 million contact lens wearers, there are approximately 200 million wearers who express dissatisfaction with their current lenses. The design of contact lenses have evolved to promote high oxygen diffusion (Dk) to promote comfort and ocular health. Since the advent of silicone hydrogel lenses in the market in the later 1990’s, silicone hydrogel lenses have dominated the lens market in recent years, making up 60% of all lens fittings in the United States in 2009. Several brands are approved for 30 day continuous, extended wear, making these lenses very popular with consumers. However, most lens wearers still express dissatisfaction with their lenses due to CLIDE-related symptoms. Controlled drug delivery methods applied to soft contact lenses deliver have been shown to deliver macromolecular comfort agents to the eye. Yet controlled drug delivery from silicone hydrogels has yet to be shown in silicone hydrogel contact lenses. This represents a large technology gap. To fill this unmet need, we have designed novel contact lenses (based on Lotrafilcon B silicone hydrogels), which are capable of controlled delivery of 120 KDa hydroxypropyl methylcellulose (HPMC) through application of biomimetic molecular imprinting. This is the first instance controlled and tailorable release of ocular therapeutics from a silicone hydrogel lens. By adjusting the ratio of acrylic acid (M) to HPMC (T) in 100 μm thick lenses, the rate of HPMC delivery can be tailored to deliver 1,000 μg HPMC for up to 60 days. By adding divinyl functional monomers (xLer) to the Lotrafilcon B mixture, significant control was granted over swelling, optical clarity and modulus.en_US
dc.rightsEMBARGO_GLOBALen_US
dc.subjectChemical Engineeringen_US
dc.titleExtended Release of Macromolecular Comfort Agents from Silicone Hydrogel Contact Lensesen_US
dc.typethesisen_US
dc.embargo.lengthMONTHS_WITHHELD:60en_US
dc.embargo.statusEMBARGOEDen_US
dc.embargo.enddate2016-04-26en_US


Files in this item

Show simple item record